Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia
- 1 June 1987
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 9 (6) , 1364-1368
- https://doi.org/10.1016/s0735-1097(87)80479-5
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Propafenone for the Treatment of Refractory Complex Ventricular Ectopic ActivityMayo Clinic Proceedings, 1986
- Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardiaThe American Journal of Cardiology, 1985
- Effect of propafenone in the wolff-parkinson-white syndrome: Electrophysiologic findings and long-term follow-upThe American Journal of Cardiology, 1984
- Antiarrhythmic and electrophysiologic effects of oral propafenoneThe American Journal of Cardiology, 1984
- Electrophysiologic testing in the upright position: Improved evaluation of patients with rhythm disturbances using a tilt tableJournal of the American College of Cardiology, 1984
- Effects of Propafenone on Induction and Maintenance of Atrioventricular Nodal Reentrant TachycardiaPacing and Clinical Electrophysiology, 1984
- European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmiasThe American Journal of Cardiology, 1984
- Clinical pharmacology of propafenone.Circulation, 1983
- Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathwayThe American Journal of Cardiology, 1982
- Ventricular Fibrillation in the Wolff-Parkinson-White SyndromeNew England Journal of Medicine, 1979